BackNeuroSense Therapeutics Overview

NeuroSense Therapeutics Total Liabilities

Latest total liabilities for NRSN: $2.6M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$2.59M
29.92% YoYΔ $596000.00 vs prior year quarter

Peer trimmed avg / median

Loading

NeuroSense Therapeutics Total Liabilities History

Loading

NeuroSense Therapeutics vs. peers: Total Liabilities Comparison

Loading

NeuroSense Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NeuroSense Therapeutics (NRSN) FAQ

As of the most recent data (December 2025), NRSN shows a total liabilities of $2.6M. That compares with $2M in the prior-year period — up 29.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NRSN's total liabilities is now $2.6M (was $2M) — a 29.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether NeuroSense Therapeutics is outperforming or lagging.

Tracking NRSN's total liabilities over time shows whether NeuroSense Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $2.6M That compares with $2M in the prior-year period — up 29.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has NeuroSense Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $2.6M) with ownership activity and broader fundamentals.